Observational Study
Copyright ©The Author(s) 2023.
World J Clin Cases. Feb 16, 2023; 11(5): 1049-1057
Published online Feb 16, 2023. doi: 10.12998/wjcc.v11.i5.1049
Table 3 Short-and medium-term outcomes
ParameterValue
Follow-upa in mo41 (r7-58)
Adjuvant chemotherapy5 (45.5)
Completed chemotherapy4 (36.4)
Recurrence3 (27.3)
Time to recurrencea in mo32 (r6-36)
Recurrence sites
Lymph node1 (9.1)
Liver1 (9.1)
Peritoneum1 (9.1)
Disease-free survival
1-yr90.9%
2-yr90.9%
3-yr75.8%
Overall survival
1-yr90.9%
2-yr90.9%
3-yr90.9%
Deaths2 (18.2)